South Asians are missing from global health databases: why this matters and what needs to change
Advances in AI are allowing scientists to mine vast amounts of genomic data to detect disease earlier, predict risk and tailor treatments to individuals. But at the heart of this lies an old, constant problem – the data used to build these tools lack diversity. South Asian scientists now want to build their own tools
South Asians are underrepresented in global health databases, a critical issue that affects their health outcomes and access to accurate healthcare. Despite more than one in ten adults worldwide living with diabetes, South Asians face higher risks, including type 2 diabetes, cardiovascular disease, and asthma. However, genetic data used to study these diseases often comes from European populations, leading to inaccurate tools and predictions for South Asians.
Integrated biobanks like the U.K. Biobank have transformed biomedical research, but South Asians are largely absent from these datasets. According to Bhramar Mukherjee, a senior associate dean of public health data science, nearly 20% of the world is being neglected in multi-modal data integration, denying them the opportunity to attain optimal health.
South Asia's diverse population, shaped by migration, cultural diversity, and endogamy, is often lumped together, obscuring important genetic differences. Research funding and infrastructure have historically favored high-income countries, leaving low- and middle-income countries with inadequate resources for comprehensive studies.
To ensure equitable and accurate healthcare for South Asians, diagnostic thresholds, risk scores, and prediction models must be validated and recalibrated using data specific to their populations.
Written by urgent.news from The Hindu Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.